Carlquist JF - Search Results

1

Integration of genetic, clinical, and INR data to refine warfarin dosing.

Lenzini P, Wadelius M, Kimmel S, Anderson JL, Jorgensen AL, Pirmohamed M, Caldwell MD, Limdi N, Burmester JK, Dowd MB, Angchaisuksiri P, Bass AR, Chen J, Eriksson N, Rane A, Lindh JD, Carlquist JF, Horne BD, Grice G, Milligan PE, Eby C, Shin J, Kim H, Kurnik D, Stein CM, McMillin G, Pendleton RC, Berg RL, Deloukas P, Gage BF. Lenzini P, et al. Among authors: carlquist jf. Clin Pharmacol Ther. 2010 May;87(5):572-8. doi: 10.1038/clpt.2010.13. Epub 2010 Apr 7. Clin Pharmacol Ther. 2010. PMID: 20375999 Free PMC article.

2

HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies.

Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JL. Carlquist JF, et al. Circulation. 1991 Feb;83(2):515-22. doi: 10.1161/01.cir.83.2.515. Circulation. 1991. PMID: 1825038

3

Recovery and phenotypic identification of in vivo-activated lymphocytes from mouse cardiac allografts.

Carlquist JF, Shelby J, Hammond EH, Greenwood JH, Anderson JL. Carlquist JF, et al. Transplantation. 1990 Aug;50(2):349-51. Transplantation. 1990. PMID: 2382303 No abstract available.

4

Propagation and characterization of lymphocytes from rejecting human cardiac allografts.

Carlquist JF, Hammond EH, Anderson JL. Carlquist JF, et al. J Heart Transplant. 1988 Nov-Dec;7(6):397-406. J Heart Transplant. 1988. PMID: 3062146

5

Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy.

Anderson JL, Carlquist JF, Hammond EH. Anderson JL, et al. Among authors: carlquist jf. Lancet. 1982 Nov 20;2(8308):1124-7. doi: 10.1016/s0140-6736(82)92786-6. Lancet. 1982. PMID: 6183539

6

Accelerated rejection of murine cardiac allografts by murine cytomegalovirus-infected recipients. Lack of haplotype specificity.

Carlquist JF, Shelby J, Shao YL, Greenwood JH, Hammond ME, Anderson JL. Carlquist JF, et al. J Clin Invest. 1993 Jun;91(6):2602-8. doi: 10.1172/JCI116499. J Clin Invest. 1993. PMID: 8390486 Free PMC article.

7

HLA, autoimmunity, and rheumatic heart disease. Apparent or real associations?

Carlquist JF, Anderson JL. Carlquist JF, et al. Circulation. 1993 Jun;87(6):2060-2. doi: 10.1161/01.cir.87.6.2060. Circulation. 1993. PMID: 8504522 No abstract available.

8

Cytokines and rejection of mouse cardiac allografts.

Carlquist JF, Edelman LS, White W, Shelby J, Anderson JL. Carlquist JF, et al. Transplantation. 1996 Oct 27;62(8):1160-6. doi: 10.1097/00007890-199610270-00022. Transplantation. 1996. PMID: 8900318

9

Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.

Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP. Anderson JL, et al. Among authors: carlquist jf. J Am Coll Cardiol. 1998 Jul;32(1):35-41. doi: 10.1016/s0735-1097(98)00203-4. J Am Coll Cardiol. 1998. PMID: 9669246 Free article.

10

Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease.

Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE, Pearson RR. Anderson JL, et al. Among authors: carlquist jf. Circulation. 2000 Sep 12;102(11):1227-32. doi: 10.1161/01.cir.102.11.1227. Circulation. 2000. PMID: 10982535 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page